NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the second quarter were flat year over year, as it experienced a late-quarter slowdown in instrument systems orders.

The company posted Q2 revenues of $451 million, short of the average Wall Street estimate of $466.4 million. It reported a profit of $89.3 million, or $1.03 per share, during the quarter, compared to a profit of $97.7 million, or $1.09 per share, a year ago.

On a non-GAAP basis, Waters had EPS of $1.08, below the average analyst estimate of $1.21.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.